Eli Lilly

News

Heart claims unlock Medicare coverage of obesity drugs

Medicare has loosened restrictions on the reimbursement of obesity drugs, thanks to clinical data showing they can improve cardiovascular outcomes, but their price could b

News

Lilly adds Amazon Pharmacy to LillyDirect DTC channel

Amazon Pharmacy will provide dispensing for Eli Lilly’s recently launched LillyDirect service, a direct-to-consumer (DTC) telehealth channel that has caused a stir in the

News

Lilly’s Alzheimer’s drug delayed as FDA seeks adcomm

The FDA has said it will seek the advice of independent advisors before it concludes its review of Eli Lilly’s amyloid-targeting Alzheimer’s disease therapy donanemab, del

News

After Roche’s exit, Blueprint passes Gavreto on to Rigel

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug

News

Pfizer’s Litfulo becomes first NHS drug for alopecia areata

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition t

News

Could Novo-Catalent deal face antitrust hurdles?

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities

Heart claims unlock Medicare coverage of obesity drugs

Lilly adds Amazon Pharmacy to LillyDirect DTC channel

Lilly’s Alzheimer’s drug delayed as FDA seeks adcomm

After Roche’s exit, Blueprint passes Gavreto on to Rigel

Pfizer’s Litfulo becomes first NHS drug for alopecia areata

Could Novo-Catalent deal face antitrust hurdles?

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Eli Lilly

Editor's Picks